These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 42486)

  • 1. Beta-adrenoceptor blocking drugs at maximum beta-blockade in relation to dose and plasma concentration.
    Gugler R; Krist R; Raczinski H; Höffgen K; Boden G
    Cardiology; 1979; 64 Suppl 1():20-4. PubMed ID: 42486
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
    Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G
    Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.
    Zaagsma J; Meems L; Boorsma M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):29-36. PubMed ID: 18685
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane stabilizing activity and beta-adrenoceptor antagonist-induced bradycardia in conscious dogs.
    Boucher M; Chapuy E; Duchêne-Marullaz P
    Eur J Pharmacol; 1992 Feb; 211(3):343-9. PubMed ID: 1352254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of selectivity and non-selectivity in beta-adrenoceptor blocking drugs.
    Bonelli J
    Br J Clin Pharmacol; 1982; 13(Suppl 2):199S-200S. PubMed ID: 6125170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of four beta-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate.
    Hall PE; Smith SR; Kendall MJ
    Clin Sci (Lond); 1987 Jun; 72(6):679-82. PubMed ID: 2885122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of isoprenaline and -blocking agents on stroke volume regulation.
    Fenyvesi T; Hadházy P
    Eur J Pharmacol; 1973 Apr; 22(1):105-8. PubMed ID: 4145253
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of beta 1- and beta 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly.
    Kaila T; Iisalo E; Lehtonen A; Saarimaa H
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):839-49. PubMed ID: 7912102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
    Harms HH; Gooren L; Spoelstra AJ; Hesse C; Verschoor L
    Br J Clin Pharmacol; 1978 Jan; 5(1):19-26. PubMed ID: 23133
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peripheral platelet count and the isoprenaline-induced splenic platelet pooling in response to beta-adrenoceptor blockade.
    Fredén K; Vilén L; Lundborg P; Olsson LB; Kutti J
    Scand J Haematol; 1979 Sep; 23(3):245-50. PubMed ID: 41319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency.
    Boucher M; Duchene-Marullaz P
    Br J Pharmacol; 1980 Oct; 70(2):335-40. PubMed ID: 6107135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide.
    Twum-Barima Y; Ahmad D; Hamilton JT; Carruthers SG
    Clin Pharmacol Ther; 1982 Sep; 32(3):289-94. PubMed ID: 6125288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats.
    Ozawa H; Matsubara T; Chen CS
    Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension.
    Franssen C; Wollersheim H; de Haan A; Thien T
    J Clin Pharmacol; 1992 Jul; 32(7):652-9. PubMed ID: 1353506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.